_CSPC Official website

Biological medicines

PEGylated Recombinant Human Granulocyte Colony-Stimulating Factor Injection

When patients with non-myeloid malignancies receive antitumor therapy that inhibits bone marrow with clinically meaningful febrile neutropenia, this drug reduces the incidence of infections caused by febrile neutropenia。 This product is not used for mobilization of peripheral blood progenitor cells from hematopoietic stem cell transplantation。

500万彩票 500万彩票 五百万彩票 500万彩票 秒速时时彩 极速时时彩 500万彩票 秒速时时彩 快乐时时彩 秒速时时彩